167 related articles for article (PubMed ID: 22585683)
21. Pulmonary metastases in pseudomyxoma peritonei syndrome.
Mortman KD; Sugarbaker PA; Shmookler BM; DeGuzman VC; Soberman MS
Ann Thorac Surg; 1997 Nov; 64(5):1434-6. PubMed ID: 9386716
[TBL] [Abstract][Full Text] [Related]
22. Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models.
Flatmark K; Davidson B; Kristian A; Stavnes HT; Førsund M; Reed W
Hum Pathol; 2010 Aug; 41(8):1109-19. PubMed ID: 20338618
[TBL] [Abstract][Full Text] [Related]
23. A case of pseudomyxoma peritonei with a unique palliative therapy.
Tahseen S; McLean G
J Obstet Gynaecol; 2003 Nov; 23(6):679-80. PubMed ID: 14617486
[No Abstract] [Full Text] [Related]
24. Unusual tumors of the appendix and pseudomyxoma peritonei.
Carr NJ; Sobin LH
Semin Diagn Pathol; 1996 Nov; 13(4):314-25. PubMed ID: 8946609
[TBL] [Abstract][Full Text] [Related]
25. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei.
Bibi R; Pranesh N; Saunders MP; Wilson MS; O'dwyer ST; Stern PL; Renehan AG
Br J Cancer; 2006 Nov; 95(9):1258-64. PubMed ID: 17031402
[TBL] [Abstract][Full Text] [Related]
26. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
Choudry HA; Mavanur A; O'Malley ME; Zeh HJ; Guo Z; Bartlett DL
Ann Surg Oncol; 2012 May; 19(5):1402-9. PubMed ID: 22302271
[TBL] [Abstract][Full Text] [Related]
27. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary.
Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ
Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376
[TBL] [Abstract][Full Text] [Related]
28. Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.
Flatmark K; Reed W; Halvorsen T; Sørensen O; Wiig JN; Larsen SG; Fodstad Ø; Giercksky KE
BMC Cancer; 2007 Jun; 7():116. PubMed ID: 17603904
[TBL] [Abstract][Full Text] [Related]
29. What is pseudomyxoma peritonei?
King JE
Nursing; 2007 Dec; 37(12 Pt.1):22. PubMed ID: 18090611
[No Abstract] [Full Text] [Related]
30. [A case of pseudomyxoma peritonei successfully treated with intra-peritoneal hyperthermia].
Okugawa T; Yamada K; Futamura N; Ida M; Nishimura K; Nose Y; Uematsu A; Toyoda N
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1345-8. PubMed ID: 8258736
[No Abstract] [Full Text] [Related]
31. Pseudomyxoma peritonei: the 'controversial' disease.
Galani E; Marx GM; Steer CB; Culora G; Harper PG
Int J Gynecol Cancer; 2003; 13(4):413-8. PubMed ID: 12911716
[TBL] [Abstract][Full Text] [Related]
32. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.
Shelekhova KV; Zhuravlev AS; Krylova DD; Konstantinov AS; Shtan LV; Kheinshtein VA
Int J Surg Pathol; 2017 Sep; 25(6):563-566. PubMed ID: 28449606
[TBL] [Abstract][Full Text] [Related]
33. Mucocele of the appendix secondary to endometriosis. Report of two cases, one with localized pseudomyxoma peritonei.
Driman DK; Melega DE; Vilos GA; Plewes EA
Am J Clin Pathol; 2000 Jun; 113(6):860-4. PubMed ID: 10874887
[TBL] [Abstract][Full Text] [Related]
34. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
[TBL] [Abstract][Full Text] [Related]
35. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
Prayson RA; Hart WR; Petras RE
Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
[TBL] [Abstract][Full Text] [Related]
36. Extraperitoneal presentation of pseudomyxoma peritonei as retroperitoneal invasion with skin fistula-a case report.
Chang-Yun L; Mao-Chi H; Yonemura Y; Ishibashi H; Sako S; Kitai T; Matsuki N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1998-2001. PubMed ID: 22202264
[TBL] [Abstract][Full Text] [Related]
37. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.
Brueggen C; Baird G; Meisheid A
Clin J Oncol Nurs; 2007 Aug; 11(4):525-32. PubMed ID: 17723965
[TBL] [Abstract][Full Text] [Related]
38. Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.
Kuracha MR; Thomas P; Loggie BW; Govindarajan V
Cancer Med; 2016 Apr; 5(4):711-9. PubMed ID: 26833741
[TBL] [Abstract][Full Text] [Related]
39. Intraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literature.
Rosenberger LH; Stein LH; Witkiewicz AK; Kennedy EP; Yeo CJ
J Gastrointest Surg; 2012 Apr; 16(4):762-70. PubMed ID: 22258877
[TBL] [Abstract][Full Text] [Related]
40. [An analysis of pathologic features and prognostic factors of 10 cases with pseudomyxoma peritonei].
Zhou X; Du X
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):543-6. PubMed ID: 8556915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
